Free tool
FAERS Monitor: Lyrica Cr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209501 or its brand name (Lyrica Cr, Pregabalin). Reports on generic versions are filed under their own applications.
Reports
81,701
Serious
70,818
87% of reports
Hospitalization
33,840
Death reported
12,465
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,667
- off label use5,813
- fatigue5,735
- pain5,131
- nausea5,086
- toxicity to various agents4,777
- headache4,473
- dyspnoea4,269
- dizziness4,260
- diarrhoea3,888
- vomiting3,775
- malaise3,495
- arthralgia3,369
- somnolence3,332
- pyrexia3,222
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 59 |
| 2007 | 211 |
| 2008 | 462 |
| 2009 | 367 |
| 2010 | 548 |
| 2011 | 572 |
| 2012 | 826 |
| 2013 | 1,053 |
| 2014 | 1,156 |
| 2015 | 1,630 |
| 2016 | 2,144 |
| 2017 | 2,596 |
| 2018 | 4,082 |
| 2019 | 5,849 |
| 2020 | 7,546 |
| 2021 | 8,337 |
| 2022 | 8,622 |
| 2023 | 8,290 |
| 2024 | 9,820 |
| 2025 | 9,917 |
| 2026 | 7,607 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,972,458 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| toxicity to various agentsSignal | 4,777 | 7.5 | 7.3 | 26,242 |
| somnolenceSignal | 3,332 | 4.3 | 4.2 | 8,422 |
| pyrexiaSignal | 3,222 | 2.4 | 2.3 | 2,677 |
| dizzinessSignal | 4,260 | 2.2 | 2.1 | 2,862 |
| painSignal | 5,131 | 2.2 | 2.1 | 3,264 |
| arthralgiaSignal | 3,369 | 2.1 | 2.0 | 1,950 |
| vomitingSignal | 3,775 | 2.1 | 2.0 | 2,134 |
| malaiseSignal | 3,495 | 2.1 | 2.0 | 1,930 |
| dyspnoea | 4,269 | 1.9 | 1.9 | 2,009 |
| fatigue | 5,735 | 1.9 | 1.9 | 2,532 |
| headache | 4,473 | 1.8 | 1.8 | 1,763 |
| off label use | 5,813 | 1.7 | 1.7 | 1,790 |
| nausea | 5,086 | 1.7 | 1.6 | 1,372 |
| diarrhoea | 3,888 | 1.6 | 1.5 | 787 |
| drug ineffective | 7,667 | 1.5 | 1.5 | 1,357 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.